Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7157
Source ID: NCT00129233
Associated Drug: Valsartan
Title: Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypertension|Type 2 Diabetes Mellitus
Interventions: DRUG: Valsartan|DRUG: Amlodipine
Outcome Measures: Primary: Composite cardiovascular events including fatal or non-fatal myocardial infarction, fatal or non-fatal stroke, admission due to heart failure, coronary intervention and sudden cardiac death, At least 3 years of mean follow up period | Secondary: total death, At least 3 years of mean follow up period|cardiac function evaluated by ultrasonography, At least 3 years of mean follow up period|incidence of atrial fibrillation/flutter, At least 3 years of mean follow up period|control of blood glucose, At least 3 years of mean follow up period|renal function, At least 3 years of mean follow up period
Sponsor/Collaborators: Sponsor: Nagoya University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 1150
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Start Date: 2004-10
Completion Date: 2013-04
Results First Posted:
Last Update Posted: 2013-05-01
Locations: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan
URL: https://clinicaltrials.gov/show/NCT00129233